News

Biomet Inc., a private equity-backed maker of musculoskeletal medical products, has agreed to acquire Lanx Inc., a venture-backed maker of devices used for spinal surgery.
Zimmer Biomet Holdings on Feb. 5 announced the spin-off of its spine and dental businesses into a new and independent publicly traded company. The medical devices company expects the move to ...
RELATED: Zimmer Biomet plots $1B revenue for spine, dental spinoff ZimVie, sets launch date As a standalone company, ZimVie now takes the reins of Zimmer’s longstanding spine and dental businesses.
RELATED: Zimmer Biomet taps former Medtronic exec to lead new spine, dental spinoff For all of 2022, ZimVie is expecting to rake in revenues of $1 billion. That’s the same amount the dental and ...
With the addition of Biomet, Zimmer is the undisputed king of large joint reconstruction, by far. We expect favorable demographics, which include aging baby boomers and rising obesity, to fuel ...
Zimmer Biomet Holdings Inc. has completed the spinoff of ZimVie, the company’s former dental and spine business, through the distribution of 80.3% of ZimVie shares to Zimmer Biomet common ...
(RTTNews) - Musculoskeletal healthcare firm Zimmer Biomet Holdings Inc. (ZBH) announced Friday its intention to spin off its Spine and Dental businesses into a new and independent, publicly traded ...
(RTTNews) - Zimmer Biomet Holdings, Inc. (ZBH) announced its intention to spin off the company's Spine and Dental businesses to form a new publicly traded company. The company said, following the ...
WARSAW, Ind., Feb. 5, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced its intention to spin off the Company's ...
ZimVie is a spin-off of the dental and spine business units of Zimmer Biomet. The Company is a leading player with #5 and #6 positions in the dental and spine market respectively.
Zimmer Biomet announced that it plans to spin off its dental and spine businesses into a new company as it plans to focus on its musculoskeletal healthcare business going forward. The deal should be ...